Results 171 to 180 of about 3,533 (317)
New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology? [PDF]
Bozzatello P +5 more
europepmc +1 more source
Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada
Abstract Background and aims Canada's drug toxicity crisis has been largely attributed to a volatile fentanyl‐dominated unregulated drug supply with increasing reports of fentanyl detected in combination with benzodiazepines, stimulants and xylazine.
Shaleesa Ledlie +6 more
wiley +1 more source
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment? [PDF]
Chrysavgis L +2 more
europepmc +1 more source
Abstract Background and aims Nitazenes are a novel subclass of synthetic opioids that have been increasingly implicated in the United States (US) overdose crisis. Despite their growing presence in the illicit drug supply, national trends have not been systematically evaluated.
David T. Zhu +3 more
wiley +1 more source
Characteristics of early short-term traditional Chinese medicine in breast cancer patients: A population-based cohort study. [PDF]
Chan PW, Yu H, Hsu CH, Liu CY.
europepmc +1 more source
Drug sellers' use of a drug checking service amid the overdose crisis in British Columbia, Canada
Abstract Aims This study examined the use of a drug checking service by drug sellers in British Columbia, Canada, to assess motivations for service use and substances intended for distribution, focusing on risks associated with an unstable illicit drug market.
Pablo Gonzalez‐Nieto +7 more
wiley +1 more source
Abstract Background and aims Mindfulness‐based relapse prevention (MBRP) has been shown to be beneficial to individuals with substance use disorder (SUD) in the West. The current pilot study aimed at testing the feasibility of MBRP in a Chinese population.
Ka Tsun Ting +11 more
wiley +1 more source
Studies on the most traded medicinal plants from the dolpa district of nepal [PDF]
Gewali Mohan B
core +1 more source

